NIP
AKRO

Nicholas Investment Partners’s Akero Therapeutics AKRO Stock Holding History

Nicholas Investment Partners’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-61,612
Closed -$2.93M – 208
2025
Q3 		$2.93M Buy
61,612
+22,120
+56% +$1.07M 0.22% 146
2025
Q2 		$2.11M Buy
+39,492
New +$1.79M 0.19% 152

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Nicholas Investment Partners's AKRO Position: Q4 2025 in Review

Nicholas Investment Partners sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 61,612 shares — an estimated $2.93M sold.

Nicholas Investment Partners first reported a position in AKRO in Q2 2025 and held it in 2 quarters. The position peaked at $2.93M in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Nicholas Investment Partners reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Nicholas Investment Partners sold 61,612 Akero Therapeutics shares in Q4 2025, an estimated $2.93M.
  • Nicholas Investment Partners first reported a position in Akero Therapeutics in Q2 2025 and held it in 2 quarters.
  • Nicholas Investment Partners's Akero Therapeutics position peaked at $2.93M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Nicholas Investment Partners's 13F filing for Q4 2025, filed 13 Feb 2026.